- The NeuroCircuit
- Posts
- Weekly Signal 20 | Inner-Speech BCI, ENCELTO milestone đź§
Weekly Signal 20 | Inner-Speech BCI, ENCELTO milestone đź§
BCI, industry moves, and neural privacy—this week’s signals.

Table of Contents
đź§ Weekly Signal
Neurotechnology News | August 9 – August 15, 2025
Let's cut through the noise this week!
This week, we saw a peer-reviewed brain–computer interface decode inner speech in paralyzed patients and the first commercial ENCELTO procedure for macular telangiectasia. Meanwhile, neuromodulation financing accelerated and neural data laws gained clarity. Bottom line: core clinical translation is advancing as governance and capital align.
đź§ SCIENCE & CLINICAL TRIALS
🟢 BCI decodes “inner speech” with a user-controlled password\
Published: August 14, 2025
Read more ➡️ Nature News / Cell
Researchers implanted microelectrode arrays and used AI to decode imagined speech in people with severe paralysis, adding a “think-to-unlock” passphrase to prevent unintended decoding. Results show near–real-time decoding of internal chatter and introduce a concrete privacy control.
💡 Big Picture: Thought-to-text BCIs are moving beyond attempted speech toward true inner speech — forcing privacy-by-design into neurotech.
🟢 First FDA-approved MacTel therapy (ENCELTO) performed and shipped
Published: August 11–12, 2025
Read more ➡️ Modern Retina / Neurotech Pharmaceuticals press release
Neurotech began commercial manufacturing, shipment, and the first surgical procedure of ENCELTO (encapsulated cell-based gene therapy) for idiopathic Macular Telangiectasia Type 2. This marks the clinical rollout of the first FDA-approved therapy for MacTel.
💡 Big Picture: Beyond approval, real-world deployment has started — the milestone that actually changes patient access.
đź’Ľ INDUSTRY & STARTUPS
🟢 SetPoint Medical raises $140M to commercialize neuroimmune modulation for RA
Published: August 11, 2025
Read more ➡️ Yahoo Finance / Company statement — SetPoint press release
Fresh financing (Series C tranche + Series D) follows FDA approval of SetPoint’s implant that stimulates the vagus nerve to modulate inflammation in rheumatoid arthritis. Proceeds target U.S. launch and pipeline expansion in other autoimmune diseases.
💡 Big Picture: Bioelectronic medicine is scaling from trials to commercialization — with major strategics watching the space.
🏛️ POLICY & ETHICS
🟢 States sharpen definitions of “neural data” in privacy laws
Published: August 12, 2025
Read more ➡️ Future of Privacy Forum memo
FPF details how four U.S. states now explicitly regulate “neural/neurotechnology data,” highlighting divergent definitions and protections emerging across statutes. Coverage this week underscores growing legislative focus on mental-privacy as BCIs evolve.
đź’ˇ Big Picture: Expect a patchwork: compliance for neurotech products will hinge on jurisdiction-specific definitions of neural data.
⚡ Weekly Signal Summary Table
Signal | Insight | Future Impact |
---|---|---|
Inner-speech BCI | Real-time decoding + “think-to-unlock” | Privacy-by-design becomes a BCI requirement. |
MacTel therapy performed | ENCELTO moves from approval to first surgeries | Broader retinal gene-therapy care pathways. |
SetPoint $140M | Capital to launch RA neurostimulation | Bioelectronic medicine enters mainstream clinics. |
Neural data laws | States define “neural data” differently | Fragmented compliance; need for harmonization. |
🎯 Community Challenge
Ready to take neurotech to the next level? Share your insights, projects, ideas, our upcoming list of NeuroHacks, or your own groundbreaking work—and watch the inspiration ripple across the community!
How to Participate
Follow HackTheNeuron
Show us support by following us on X, Instagram and Tik Tok!
Create a Post
Show us what you’re working on—DIY projects, research breakthroughs, or even your latest neurotech musings.Use #Neurotech
This helps your ideas reach fellow enthusiasts and potential collaborators.Mention @HackTheNeuron
Tag us directly in your post so we never miss your entry—and we’ll amplify your work across our entire NeuroCircuit community!
Why Join?
Boost Your Reach: Tap into a niche but fast-growing community for extra visibility.
Build Your Network: Connect with researchers, developers, and curious tinkerers who share your passion.
Shape Neurotech’s Future: Your project or insight could spark the next big breakthrough—or inspire someone else’s.
We can’t wait to see your creativity in action! Fire up X, LinkedIn, Facebook, Instagram, or TikTok, and spread the word. Let’s spark innovation together!
🚀Recruit More Neurohackers
Your referrals are the engine that drives our community forward. Share your unique referral link with friends, colleagues, or fellow neurotech enthusiasts—and watch us grow together!
Spread the Word: Copy your personal referral link and post it on social, forums, or in emails.
Unlock Exclusive Perks: Every friend who subscribes through your link brings you closer to special rewards—insider insights, private Discord access, early project previews, and more.
Be the Catalyst: The more you share, the stronger our network becomes. Help us build the ultimate neurotech hub—one referral at a time!
✍️Help Us Improve
Your input is what will make The NeuroCircuit and Hack The Neuron better. Let us know what you’d like more of—and what we can do differently.
Share Your Ideas: Tell us which topics, features, or formats you’d love to see next.
Spot the Gaps: Let us know if anything’s missing or unclear in our content and community tools.
Shape the Experience: Whether it’s new challenges, tutorials, or platform features, your suggestions guide our roadmap.
Reply